Juvenile polyposis of childhoodD12.6

Authors:Prof. Dr. med. Peter Altmeyer, Prof. Dr. med. Guido Gerken

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

Synonym(s)

Juvenile intestinal polyposis; Juvenile Polyposis Syndrome; OMIM: 174900 175050 612242; Polyposis, gastrointestinal juvenile

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

Autosomal dominant inherited disease characterized by juvenile hamarous polyps in the gastrointestinal (GI) tract.

ClassificationThis section has been translated automatically.

A distinction is made between 3 forms, which differ in the location of the polyps:

  • generalized juvenile polyposis of the upper and lower digestive tract
  • juvenile polyposis coli juvenile gastric polyposis
  • more severe infantile form

Occurrence/EpidemiologyThis section has been translated automatically.

Prevalence: Unknown; estimated annual incidence is between 1:100,000 and 1:15,000.

EtiopathogenesisThis section has been translated automatically.

Mutations in the genes SMAD4 (18q21.1) and BMPR1A (10q22.3) are detected in 40% of patients. Gastric polyposis is more frequently found in SMAD4 carriers than in BMPR1A carriers. In about 25% of SMAD4 mutation carriers, JPS is associated with Hereditary Haemorrhagic Teleangiectasia (Juvenile Polyposis/Hereditary Haemorrhagic Teleangiectasia Syndrome).

ManifestationThis section has been translated automatically.

Infancy, childhood, youth, adulthood

Clinical featuresThis section has been translated automatically.

In all subtypes of JIP the clinical signs are isolated bleeding in the rectum, anemia, abdominal pain, intussusception and diarrhea. Rectal prolapse and spontaneous anal excretion of polyps has been observed in juvenile polyposis coli and in generalized juvenile polyposis.

DiagnosisThis section has been translated automatically.

Composite diagnosis consisting of clinical picture, family history, endoscopic findings and histological analysis of the polyps, molecular analysis.

> 5 juvenile polyps in the colon and/or rectum; juvenile polyps in the entire digestive tract including the stomach; any number of polyps in cases of JIP in the family.

Differential diagnosisThis section has been translated automatically.

Complication(s)This section has been translated automatically.

Possible accompanying symptoms are growth retardation and edema.

TherapyThis section has been translated automatically.

If the number of polyps remains low, endoscopic polypectomy is the therapeutic gold standard. Because of the risk of carcinoma and a further extension of the polyposis, surgical intervention of a colectomy with proctectomy and ileo-anal anastomosis can also be recommended.

Progression/forecastThis section has been translated automatically.

The prognosis of JIP is determined by the risk of developing gastrointestinal or pancreatic carcinoma after the age of 20. The cumulative risk of developing a malignoma in patients with JIP is 20% at age 35 and 68% at age 60. The cancer risk is even higher in patients with generalized juvenile polyposis.

Authors

Last updated on: 29.10.2020